Adverum Biotechnologies
ADVM
ADVM was delisted on the 8th of December, 2025.
58 hedge funds and large institutions have $30.1M invested in Adverum Biotechnologies in 2025 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 9 increasing their positions, 18 reducing their positions, and 29 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
11.48% less ownership
Funds ownership: 78.54% → 67.06% (-11%)
17% less funds holding
Funds holding: 70 → 58 (-12)
25% less call options, than puts
Call options by funds: $3K | Put options by funds: $4K
38% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 29
50% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 18
57% less capital invested
Capital invested by funds: $69.8M → $30.1M (-$39.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$1.15M |
| 2 |
Millennium Management
New York
|
+$958K |
| 3 |
PWA
Principia Wealth Advisory
Dallas,
Texas
|
+$930K |
| 4 |
BCM
BML Capital Management
Zionsville,
Indiana
|
+$882K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$219K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$7.69M |
| 2 |
BlackRock
New York
|
-$2.83M |
| 3 |
State Street
Boston,
Massachusetts
|
-$826K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$745K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$407K |
ADVM Hedge Fund Activity: Q2 2025 in Review
58 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Adverum Biotechnologies (ADVM) for Q2 2025, worth a combined $30.1M — down 57% from $69.8M a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of ADVM and 18 opened new positions — a net loss of 11 holders — while 18 trimmed existing stakes and 9 added.
The largest buyer was Renaissance Technologies, adding an estimated $1.15M. The largest seller was Franklin Resources, exiting entirely with an estimated $7.69M sold.
- 58 institutional investors held Adverum Biotechnologies (ADVM) as of Q2 2025, down from 70 in Q1 2025.
- Funds reported $30.1M of Adverum Biotechnologies stock for Q2 2025, down 57% quarter-over-quarter.
- 18 funds opened new Adverum Biotechnologies positions in Q2 2025 and 29 closed out, a net change of -11 holders.
- The largest Adverum Biotechnologies buyer in Q2 2025 was Renaissance Technologies, an estimated $1.15M added.
- The largest Adverum Biotechnologies seller in Q2 2025 was Franklin Resources, an estimated $7.69M sold.
Based on aggregated 13F filings for Q2 2025.